LONGLEAF HOSPITAL
1. Target Overview & Investment Thesis
LONGLEAF HOSPITAL is a 139-bed suburban community hospital in nan, LA with $36.6M in net patient revenue and a 33.0% operating margin. The hospital serves a payer mix of 4.6% Medicare, 12.7% Medicaid, and 82.7% commercial.
Thesis: Turnaround. Our ML models identify $2.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 33.0% to 40.3% (+736bps).
| Net Revenue HCRIS | $36.6M |
| Current EBITDA COMPUTED | $12.1M |
| Operating Margin COMPUTED | 33.0% |
| Occupancy HCRIS | 85.9% |
| Revenue / Bed COMPUTED | $263K |
| Net-to-Gross HCRIS | 35.6% |
| Distress Probability ML | 43.1% |
2. Market Context & Competitive Position
LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of 33.0% places it above the state median. Among 43 size-comparable peers (70-278 beds), the median margin is -4.9%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (70-278), prioritizing same-state peers. 43 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| LONGLEAF HOSPITAL (Target) | LA | 139 | $36.6M | 33.0% |
| CHILDRENS HOSPITAL | LA | 189 | $523.4M | 6.7% |
| BATON ROUGE GENERAL | LA | 251 | $445.5M | -6.7% |
| ST. TAMMANY PARISH HOSPITAL | LA | 213 | $434.6M | 4.5% |
| OCHSNER LSU HEALTH SHREVEPORT | LA | 273 | $395.6M | -50.0% |
| OCHSNER MEDICAL CENTER - BATON | LA | 171 | $371.4M | -11.5% |
| TOURO INFIRMARY | LA | 270 | $369.4M | -3.7% |
| ST. FRANCES CABRINI HOSPITAL | LA | 268 | $363.0M | 2.3% |
| WOMANS HOSPITAL | LA | 228 | $345.8M | -8.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $769K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $732K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $725K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $445K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $23K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $12.1M |
| + RCM Uplift | +$2.7M |
| Pro Forma EBITDA | $14.8M |
| Current Margin | 33.0% |
| Pro Forma Margin | 40.3% |
| WC Released (1x) | $1.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $18.6M | $106.6M | 5.74x | 41.8% |
| Base (11x exit) | 10.0x | 11.0x | $18.6M | $123.3M | 6.64x | 46.0% |
| Bull Case | 9.0x | 11.0x | $16.7M | $138.2M | 8.27x | 52.6% |
| Bull (12x exit) | 9.0x | 12.0x | $16.7M | $155.7M | 9.31x | 56.2% |
| Bear Case | 11.0x | 10.0x | $20.4M | $87.1M | 4.26x | 33.6% |
| Bear (11x exit) | 11.0x | 11.0x | $20.4M | $102.4M | 5.01x | 38.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 43 hospitals with 70-278 beds
- Same-state prioritization (n=44)
- Comp margins: P25=-12.5% / P50=-4.9% / P75=2.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.